Robb Gary Charles sold CORT
December 24, 2025 · Form 4 insider transaction
Robb Gary Charles sold 80,284 shares of Corcept Therapeutics Incorporated at $83.59 per share, a transaction worth $6.71M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options.; Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, and 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.